42 participants
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-16
- Start Date:
- 2020-08-31
- Completion:
- 2030-06-30
Conditions
- Melanoma Stage III
- Melanoma Stage IV
- Skin Cancer Stage III
- Skin Cancer Stage IV
- Drug-Induced Colitis
- Drug Toxicity
- Immune-related Adverse Event
Interventions
- DRUG
No Results Yet